These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 24423612

  • 1. Hedgehog-GLI signaling inhibition suppresses tumor growth in squamous lung cancer.
    Huang L, Walter V, Hayes DN, Onaitis M.
    Clin Cancer Res; 2014 Mar 15; 20(6):1566-75. PubMed ID: 24423612
    [Abstract] [Full Text] [Related]

  • 2. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
    You M, Varona-Santos J, Singh S, Robbins DJ, Savaraj N, Nguyen DM.
    J Thorac Cardiovasc Surg; 2014 Jan 15; 147(1):508-16. PubMed ID: 24094913
    [Abstract] [Full Text] [Related]

  • 3. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
    Wickström M, Dyberg C, Shimokawa T, Milosevic J, Baryawno N, Fuskevåg OM, Larsson R, Kogner P, Zaphiropoulos PG, Johnsen JI.
    Int J Cancer; 2013 Apr 01; 132(7):1516-24. PubMed ID: 22949014
    [Abstract] [Full Text] [Related]

  • 4. Hedgehog signaling drives cellular survival in human colon carcinoma cells.
    Mazumdar T, DeVecchio J, Shi T, Jones J, Agyeman A, Houghton JA.
    Cancer Res; 2011 Feb 01; 71(3):1092-102. PubMed ID: 21135115
    [Abstract] [Full Text] [Related]

  • 5. The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer.
    Mazumdar T, DeVecchio J, Agyeman A, Shi T, Houghton JA.
    Oncotarget; 2011 Aug 01; 2(8):638-45. PubMed ID: 21860067
    [Abstract] [Full Text] [Related]

  • 6. Regulation of DNA damage following termination of Hedgehog (HH) survival signaling at the level of the GLI genes in human colon cancer.
    Agyeman A, Mazumdar T, Houghton JA.
    Oncotarget; 2012 Aug 01; 3(8):854-68. PubMed ID: 23097684
    [Abstract] [Full Text] [Related]

  • 7. HH/GLI signalling as a new therapeutic target for patients with oral squamous cell carcinoma.
    Yan M, Wang L, Zuo H, Zhang Z, Chen W, Mao L, Zhang P.
    Oral Oncol; 2011 Jun 01; 47(6):504-9. PubMed ID: 21536478
    [Abstract] [Full Text] [Related]

  • 8. Gli as a novel therapeutic target in malignant pleural mesothelioma.
    Li H, Lui N, Cheng T, Tseng HH, Yue D, Giroux-Leprieur E, Do HT, Sheng Q, Jin JQ, Luh TW, Jablons DM, He B.
    PLoS One; 2013 Jun 01; 8(3):e57346. PubMed ID: 23483902
    [Abstract] [Full Text] [Related]

  • 9. Blocking Hedgehog survival signaling at the level of the GLI genes induces DNA damage and extensive cell death in human colon carcinoma cells.
    Mazumdar T, Devecchio J, Agyeman A, Shi T, Houghton JA.
    Cancer Res; 2011 Sep 01; 71(17):5904-14. PubMed ID: 21747117
    [Abstract] [Full Text] [Related]

  • 10. DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.
    Gruber W, Hutzinger M, Elmer DP, Parigger T, Sternberg C, Cegielkowski L, Zaja M, Leban J, Michel S, Hamm S, Vitt D, Aberger F.
    Oncotarget; 2016 Feb 09; 7(6):7134-48. PubMed ID: 26784250
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.
    Benvenuto M, Masuelli L, De Smaele E, Fantini M, Mattera R, Cucchi D, Bonanno E, Di Stefano E, Frajese GV, Orlandi A, Screpanti I, Gulino A, Modesti A, Bei R.
    Oncotarget; 2016 Feb 23; 7(8):9250-70. PubMed ID: 26843616
    [Abstract] [Full Text] [Related]

  • 12. Targeting the hedgehog-glioma-associated oncogene homolog pathway inhibits bleomycin-induced lung fibrosis in mice.
    Moshai EF, Wémeau-Stervinou L, Cigna N, Brayer S, Sommé JM, Crestani B, Mailleux AA.
    Am J Respir Cell Mol Biol; 2014 Jul 23; 51(1):11-25. PubMed ID: 24450438
    [Abstract] [Full Text] [Related]

  • 13. Gant61 ameliorates CCl4-induced liver fibrosis by inhibition of Hedgehog signaling activity.
    Jiayuan S, Junyan Y, Xiangzhen W, Zuping L, Jian N, Baowei H, Lifang J.
    Toxicol Appl Pharmacol; 2020 Jan 15; 387():114853. PubMed ID: 31816328
    [Abstract] [Full Text] [Related]

  • 14. Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma.
    Mori Y, Okumura T, Tsunoda S, Sakai Y, Shimada Y.
    Oncology; 2006 Jan 15; 70(5):378-89. PubMed ID: 17179732
    [Abstract] [Full Text] [Related]

  • 15. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
    Arnhold V, Boos J, Lanvers-Kaminsky C.
    Cancer Chemother Pharmacol; 2016 Mar 15; 77(3):495-505. PubMed ID: 26781311
    [Abstract] [Full Text] [Related]

  • 16. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
    Grzelak CA, Martelotto LG, Sigglekow ND, Patkunanathan B, Ajami K, Calabro SR, Dwyer BJ, Tirnitz-Parker JE, Watkins DN, Warner FJ, Shackel NA, McCaughan GW.
    J Hepatol; 2014 Jan 15; 60(1):143-51. PubMed ID: 23978713
    [Abstract] [Full Text] [Related]

  • 17. Hedgehog signaling regulates telomerase reverse transcriptase in human cancer cells.
    Mazumdar T, Sandhu R, Qadan M, DeVecchio J, Magloire V, Agyeman A, Li B, Houghton JA.
    PLoS One; 2013 Jan 15; 8(9):e75253. PubMed ID: 24086482
    [Abstract] [Full Text] [Related]

  • 18. HEDGEHOG/GLI Modulates the PRR11-SKA2 Bidirectional Transcription Unit in Lung Squamous Cell Carcinomas.
    Sun Y, Xu D, Zhang C, Wang Y, Zhang L, Qiao D, Bu Y, Zhang Y.
    Genes (Basel); 2021 Jan 19; 12(1):. PubMed ID: 33477943
    [Abstract] [Full Text] [Related]

  • 19. Widespread Expression of Hedgehog Pathway Components in a Large Panel of Human Tumor Cells and Inhibition of Tumor Growth by GANT61: Implications for Cancer Therapy.
    Réda J, Vachtenheim J, Vlčková K, Horák P, Vachtenheim J, Ondrušová L.
    Int J Mol Sci; 2018 Sep 10; 19(9):. PubMed ID: 30201866
    [Abstract] [Full Text] [Related]

  • 20. Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.
    Ramaswamy B, Lu Y, Teng KY, Nuovo G, Li X, Shapiro CL, Majumder S.
    Cancer Res; 2012 Oct 01; 72(19):5048-59. PubMed ID: 22875023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.